T Cell News and Research

Latest T Cell News and Research

Study sheds light on the role of B cells in cancer immunotherapy

Cancer patients responded better to immunotherapy and had a better prognosis if their melanoma tumors contained specific clusters of B cells, according to new research from Lund University in Sweden.

16 Jan 2020

Research collaboration reveals potential treatment option for incurable blood cancers

Today, OncoTartis, Inc. and Children's Cancer Institute jointly announced the publication of two research manuscripts in a leading onco-hematological journal Leukemia, both devoted to the OncoTartis' clinical drug candidate OT-82.

16 Jan 2020

Study shows how extracellular vesicles help melanoma cells to spread

A new study from Finland sheds fresh light on how melanoma cells interact with other cells via extracellular vesicles they secrete.

16 Jan 2020

Drinking low-fat milk associated with less aging in adults, study shows

A new study shows drinking low-fat milk -- both nonfat and 1% milk -- is significantly associated with less aging in adults.

16 Jan 2020

Study identifies molecular 'bridge' between ALS-causing genes

The enzyme Gemin3 was identified as the molecular 'bridge' between genes whose mutation or disruption causes amyotrophic lateral sclerosis, according to a new study in Nature's Scientific Reports from scientists at the University of Malta.

16 Jan 2020

Harmful genetic mutations in healthy donors' stem cells may create problems in AML patients

A stem cell transplant - also called a bone marrow transplant - is a common treatment for blood cancers, such as acute myeloid leukemia.

16 Jan 2020

'Methylation clock' gene found to have functional role in aging of the eye

A lengthy-named gene called Elongation of Very Long Chain Fatty Acids Protein 2 or ELOVL2 is an established biomarker of age.

16 Jan 2020

Advanced BioMatrix acquires HyStem products for R&D market

Advanced BioMatrix has acquired the HyStem line of products from Lineage Cell Therapeutics – previously BioTime/ESI Bio/Glycosan.

16 Jan 2020

Researchers find potential new target for treating drug addiction

New University of Minnesota Medical School research discovers a novel potential target for treating drug addiction through "the hidden stars of the brain."

16 Jan 2020

B cell count tells how certain cancers will respond to immunotherapy

Some melanomas, sarcomas and renal cell carcinomas, but not all, have been found to respond dramatically to new drugs called immune checkpoint blockers, which exploit the body’s known capability to mount an immune response against the foreign antigen-bearing tumor cells.

15 Jan 2020

Brain parasite makes rodents unafraid of cats, other predators

Cats have the power to control the minds of rodents, through a brain parasite called Toxoplasma gondii. The pathogen exerts a strange mind control on rodents that make them lose their fear of cats and become easier to catch.

15 Jan 2020

Immune system contribution to tumor heterogeneity may influence liver cancer growth

Researchers at Mount Sinai School of Medicine say the immune system might contribute to the tumor heterogeneity seen in liver cancer that can affect the rate of cancer growth.

15 Jan 2020

Alcohol dependence results in remodeling of functional architecture in rodent’s brain

Employing advanced technologies that allow whole brain imaging at single-cell resolution, researchers at University of California San Diego School of Medicine report that in an alcohol-dependent mouse model, the rodent brain's functional architecture is substantially remodeled.

14 Jan 2020

Study shows superior functionality of Duodenum Intestine-Chip populated with organoids

Emulate, Inc. announced today a published study in collaboration with Johns Hopkins University School of Medicine, that demonstrated superior functionality of the Duodenum Intestine-Chip populated with organoids, compared to organoids alone.

14 Jan 2020

Princeton researchers uncover vital role played by a protein elevated in many cancers

Researchers at Princeton University have successfully recreated a key process involved in cell division in a test tube, uncovering the vital role played by a protein that is elevated in over 25% of all cancers.

14 Jan 2020

Parkinson’s disease could be prevented by gut microbes

One common gut organism that helps us digest food better could also be a powerful instrument in preventing or reversing the symptoms of Parkinson’s disease (PD), according to a recent study. The changes are due to the ability of this bacterium to delay the build-up of a toxic protein involved in this in the disease condition, or even to eliminate the toxin altogether.

14 Jan 2020

InDepth Pharmaceuticals to commercialize novel technique to predict kidney transplant success

InDepth Pharmaceuticals, founded by Deepak Nihalani, Ph.D., the SmartState Endowed Chair in Renal Disease Biomarkers at the Medical University of South Carolina, has taken a vital step toward commercializing an innovative diagnostic technique that could better predict kidney transplant success in patients with focal segmental glomerulosclerosis (FSGS), a kidney disease that often leads to end-stage renal failure.

14 Jan 2020

Study reveals how clotting protein and blood platelets promote immune evasion, tumor progression

A new study led by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute reveals how a clotting protein and blood platelets can promote cancer progression and suppress immune responses to cancer.

14 Jan 2020

Biomaterial-based vaccine has potential to completely eliminate AML cells

Acute myeloid leukemia (AML) is a deadly blood cancer that originates in the bone marrow and kills most of its victims within five years. Chemotherapy has been the standard AML treatment for over 40 years, and while it often causes the cancer to go into remission, it rarely completely eliminates the cancerous cells, which then lead to disease recurrence in nearly half of treated patients.

14 Jan 2020

Study shows how treatment resistance develops in patients with bile duct cancer

A new study led by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute shows how resistance to a promising targeted drug develops in patients with a rare, lethal cancer of the bile ducts called cholangiocarcinoma.

14 Jan 2020

T Cell News and Research

Latest T Cell News and Research

Study sheds light on the role of B cells in cancer immunotherapy

Research collaboration reveals potential treatment option for incurable blood cancers

Study shows how extracellular vesicles help melanoma cells to spread

Drinking low-fat milk associated with less aging in adults, study shows

Study identifies molecular 'bridge' between ALS-causing genes

Harmful genetic mutations in healthy donors' stem cells may create problems in AML patients

'Methylation clock' gene found to have functional role in aging of the eye

Advanced BioMatrix acquires HyStem products for R&D market

Researchers find potential new target for treating drug addiction

B cell count tells how certain cancers will respond to immunotherapy

Brain parasite makes rodents unafraid of cats, other predators

Immune system contribution to tumor heterogeneity may influence liver cancer growth

Alcohol dependence results in remodeling of functional architecture in rodent’s brain

Study shows superior functionality of Duodenum Intestine-Chip populated with organoids

Princeton researchers uncover vital role played by a protein elevated in many cancers

Parkinson’s disease could be prevented by gut microbes

InDepth Pharmaceuticals to commercialize novel technique to predict kidney transplant success

Study reveals how clotting protein and blood platelets promote immune evasion, tumor progression

Biomaterial-based vaccine has potential to completely eliminate AML cells

Study shows how treatment resistance develops in patients with bile duct cancer

Immunology eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

T Cell News and Research

Latest T Cell News and Research

Immunology eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in